Product Lead Software gesucht für Biotech Startup

### Minimum qualifications:
- Bachelor’s degree in Computer Science, related field, or comparable practical experience.
- 5 years of experience in software development, including web platforms and APIs in high-growth tech companies (Start-ups / scale-ups)
- 3 years of experience in software design and architecture.
- Proficiency in modern JavaScript frameworks and Python.
- Ability to fluently communicate in English and German (preferable).

### Preferable qualifications:
- 2 years of experience in a technical leadership role, managing teams of software engineers.
- Experience working with microcontrollers, sensors and actuators.
- Experience designing and implementing any of the following: APIs and SDK’s used by other developers, data and ML (Machine Learning) systems.

• Softwarearchitektur
• Produkt Management
• JavaScipt
• Python
• API

Du bist gut mit...

• Zahlen, Daten und Logik
• Organisieren und Ordnung halten
• Strukturen und strategischem Denken

Du hast bereits...

• Vollzeitbeschäftigte geführt

- Lead the research, design, development, testing and maintenance of the Mo:re web platform.
- Support the hardware team in the development Mo:re’s device firmware.
- Support the team in the necessary customer facing activities.
- Supervise both individual and team priorities and milestones.

- Lead the development of cutting-edge software solutions for our lab platform. The software contains a user interface to automatically design cell culture experiments, algorithms controlling the mo:re lab robot, machine learning-based quality control of the organoids
- Shape the product strategy and roadmap, aligning it with our vision to transform drug development.
- Grow with the company and play a pivotal role in our success.
- Collaborate with a passionate team dedicated to making a significant impact on the pharmaceutical industry.

Mo:re is building the new gold standard for organoid-based drug develompment

mo:re is a biotech startup dedicated to revolutionizing the pharmaceutical industry. Founded in 2023 and based in Hamburg, we are on a mission to establish the new gold standard for organoid-based drug development, ultimately aiming to eliminate the need for animal studies. Our innovative lab platform empowers organizations to conduct organoid cell culture studies, offering a cost-effective, faster, and more compliant alternative to traditional animal testing.

Herausforderungen

Having closed our Seed Funding round, we will begin the commercialization of our product in Q4 2024. For this, our software platform needs to be expanded.

Zielgruppe

Pharma, Biotechnology